JIN Ebitda from 2010 to 2024

ZJYL Stock   0.79  0.04  5.33%   
JIN MEDICAL EBITDA yearly trend continues to be quite stable with very little volatility. The value of EBITDA is projected to decrease to about 2.7 M. From the period between 2010 and 2024, JIN MEDICAL, EBITDA regression line of its data series had standard deviation of  919,596 and standard deviation of  919,596. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
2.8 M
Current Value
2.7 M
Quarterly Volatility
919.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check JIN MEDICAL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among JIN MEDICAL's main balance sheet or income statement drivers, such as Depreciation And Amortization of 254.9 K, Interest Expense of 8.1 K or Selling General Administrative of 2 M, as well as many indicators such as Price To Sales Ratio of 8.1, Dividend Yield of 0.0 or PTB Ratio of 4.73. JIN financial statements analysis is a perfect complement when working with JIN MEDICAL Valuation or Volatility modules.
  
Check out the analysis of JIN MEDICAL Correlation against competitors.

Latest JIN MEDICAL's Ebitda Growth Pattern

Below is the plot of the Ebitda of JIN MEDICAL INTERNATIONAL over the last few years. It is JIN MEDICAL's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in JIN MEDICAL's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

JIN Ebitda Regression Statistics

Arithmetic Mean4,029,506
Geometric Mean3,922,507
Coefficient Of Variation22.82
Mean Deviation861,941
Median4,747,790
Standard Deviation919,596
Sample Variance845.7B
Range2M
R-Value(0.86)
Mean Square Error241.6B
R-Squared0.73
Significance0.000044
Slope(176,249)
Total Sum of Squares11.8T

JIN Ebitda History

20242.7 M
20232.8 M
20223.1 M
20213.1 M
20203.2 M
20192.8 M

About JIN MEDICAL Financial Statements

JIN MEDICAL investors utilize fundamental indicators, such as Ebitda, to predict how JIN Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA2.8 M2.7 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports:
Check out the analysis of JIN MEDICAL Correlation against competitors.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Earnings Share
0.02
Revenue Per Share
0.129
Quarterly Revenue Growth
0.03
Return On Assets
0.0403
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.